I think hottod is right that 1) pursuing a Ph III PMS alone would be risky (requiring most of their existing cash and income) and 2) that partnering for PMS or licensing it out would muddy the waters for a future T/O (a large acquirer would prefer an asset not already encumbered to other parties).
However, as others have mentioned, there's still the 3rd way, external funding from a party like Blackrock. This would allow Neuren to access much more cash (several Ph 3s? lots more Ph 2s?), reduce the risks, and also avoid complications for an eventual T/O. The assumption would be that the funding party would be along for the T/O and cooperate with it. In fact, it would be the reason they're involved - their goal is a full 'exit' in a few years.
This move would dilute the eventual return with the 3rd party obviously getting a % of any final deal for their support. However, so long as you can see how giving up 15-25% equity (or agreeing to the funding party taking a similarly structured 'fee' in a T/O) now would help you increase the final T/O price by at least this 15-25% (something likely easy to argue for) then this could be an easy decision.
Funding is normally expensive. However, Neuren's in a great position with an on-market product, strong pipeline, positive cashflows and likely a relatively short time frame to exit (maybe 2-3 years, unlike a biotech startup with an exit 10 years away). Neuren would be able to drive a deal on favourable terms. In fact, I could imagine parties like Blackrock falling over themselves to assist in funding such a high quality opportunity.
As we know, there's already been a few comments from Jon & others hinting that such an arrangement may be under consideration.
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Annual Report to shareholders
Ann: 2023 Annual Report to shareholders, page-79
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 3429 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 18.000 |
2 | 582 | 17.950 |
2 | 650 | 17.500 |
2 | 2080 | 17.430 |
1 | 100 | 17.150 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 3429 | 4 |
15.400 | 2663 | 9 |
15.500 | 2500 | 1 |
15.800 | 4021 | 1 |
16.000 | 7086 | 3 |
Last trade - 14.55pm 08/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable